3T ADC values in malignant neck lesions
Age, y/Sex | Lesion | Stage | ADC, × 10−3 mm2/s |
---|---|---|---|
65/M | Sinonasal undifferentiated SCC (P) | T4N0M0 | 0.719 ± 0.157 |
35/M | Sinonasal undifferentiated SCC (P) | T4N0M0 | 1.042 ± 0.068 |
51/F | SCC Parotid (P) | T4N2M1 | 1.064 ± 0.162 |
61/M | SCC palatine tonsil (P) | T4N2BM0 | 0.847 ± 0.083 |
62/M | SCC palatine tonsil (P) | T4N3M1 | 0.733 + 0.055 |
62/M | SCC palatine tonsil (MD) | T3N1M0 | 1.261 ± 0.168 |
59/M | SCC base of tongue (P) | T2N3M0 | 0.955 ± 0.095 |
65/F | SCC soft palate (P) | T1N3M0 | 1.033 ± 0.183 |
78/F | SCC nasopharynx (W) | T4N0M0 | 1.319 ± 0.194 |
58/M | SCC supraglottis (MD) | T4N2BM0 | 1.278 + 0.070 |
83/M | SCC supraglottis (MD) | T4N0M0 | 1.138 ± 0.148 |
43/M | SCC oropharynx (MD) | T4N1M0 | 1.359 + 0.087 |
90/F | SCC orbit (W) | T4N1M1 | 1.055 ± 0.047 |
40/F | Adenosquamous cell carcinoma skull base | T4N0M0 | 1.649 ± 0.229 |
57/F | Carcinoma ex pleomorphic adenoma (parotid) | T2N1M0 | 1.241 ± 0.194 |
69/M | Orbital B-cell lymphoma | 3A | 0.438 ± 0.099 |
Note:—SCC indicates squamous cell carcinoma; W, well-differentiated; MD, moderately differentiated; P, poorly differentiated; F, female; M, male; ADC, apparent diffusion coefficient.